Literature DB >> 20228826

Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.

Yu-hua Wang1, Jian-feng Sun, Yi-min Tao, Xue-jun Xu, Zhi-qiang Chi, Jing-gen Liu.   

Abstract

AIM: To examine the relationship between the RAVE (relative activity versus endocytosis) values of opiate agonists and their dependence liability by studying several potent analgesics with special profiles in the development of physical and psychological dependence.
METHODS: The effects of (-)-cis-(3R,4S,2'R) ohmefentanyl (F9202), (+)-cis-(3R,4S,2'S) ohmefentanyl (F9204), dihydroetorphine (DHE) and morphine on [(35)S]GTP gamma S binding, forskolin-stimulated cAMP accumulation, and receptor internalization were studied in CHO cells stably expressing HA-tagged mu-opioid receptors (CHO-HA-MOR). cAMP overshoot in response to the withdrawal of these compound treatments was also tested.
RESULTS: All four agonists exhibited the same rank order of activity in stimulation of [(35)S]GTP gamma S binding, inhibition of adenylyl cyclase (AC) and induction of receptor internalization: DHE>F9204>F9202>morphine. Based on these findings and the previous in vivo analgesic data obtained from our and other laboratories, the RAVE values of the four agonists were calculated. The rank order of RAVE values was morphine>F9202>F9204>DHE. For the induction of cAMP overshoot, the rank order was F9202>or=morphine>F9204>or=DHE.
CONCLUSION: Taken in combination with previous findings of these compounds' liability to develop dependence, the present study suggests that the agonist with the highest RAVE value seems to have a relatively greater liability to develop psychological dependence relative to the agonist with the lowest RAVE value. However, the RAVE values of these agonists are not correlated with their probability of developing physical dependence or inducing cAMP overshoot, a cellular hallmark of dependence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228826      PMCID: PMC4007660          DOI: 10.1038/aps.2010.19

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  42 in total

Review 1.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

Review 2.  A RAVE about opioid withdrawal.

Authors:  V Alvarez; S Arttamangkul; J T Williams
Journal:  Neuron       Date:  2001-12-06       Impact factor: 17.173

3.  Quantitative comparison of ohmefentanyl isomers induced conditioning place preference in mice.

Authors:  G W Guo; Z H Liu; W Q Jin; H P Zhang; X J Chen; Y C Zhu; Z Q Chi
Journal:  Life Sci       Date:  2001-04-13       Impact factor: 5.037

Review 4.  Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.

Authors:  J G Liu; K J Anand
Journal:  Brain Res Brain Res Rev       Date:  2001-12

5.  Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.

Authors:  A Alt; I J McFadyen; C D Fan; J H Woods; J R Traynor
Journal:  J Pharmacol Exp Ther       Date:  2001-07       Impact factor: 4.030

6.  Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal.

Authors:  A K Finn; J L Whistler
Journal:  Neuron       Date:  2001-12-06       Impact factor: 17.173

7.  Effects of opioid receptor agonists on cAMP second messenger system.

Authors:  J G Liu; Z H Gong; B Y Qin
Journal:  Zhongguo Yao Li Xue Bao       Date:  1999-05

8.  Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization.

Authors:  Li He; Jamie Fong; Mark von Zastrow; Jennifer L Whistler
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

9.  Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.

Authors:  Jing-Gen Liu; Paul L Prather
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

10.  Addictive evaluation of cholic acid-verticinone ester, a potential cough therapeutic agent with agonist action of opioid receptor.

Authors:  Jiu-liang Zhang; Hui Wang; Chang Chen; Hui-fang Pi; Han-li Raun; Peng Zhang; Ji-zhou Wu
Journal:  Acta Pharmacol Sin       Date:  2009-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.